期刊: CANCER MEDICINE, 2021; 10 (16)
Background Clear-cell renal cell carcinoma (ccRCC) is stubborn to traditional chemotherapy and radiation treatment, which makes its clinical managemen......
期刊: CANCER MEDICINE, 2021; 10 (18)
Histone deacetylases (HDAC) family is vital for tumorigenesis and tumor progression. However, the exact role of the HDAC family in clear cell renal ce......
期刊: CANCER MEDICINE, 2021; 10 (10)
Background To compare the efficacy of first-line bevacizumab plus chemotherapy with cetuximab plus chemotherapy based on the stratification of metasta......
期刊: CANCER MEDICINE, 2021; 10 (12)
To compare the efficacy and safety of induction chemotherapy (IC) followed by intensity-modulated radiotherapy (IMRT) alone versus concurrent CCRT in ......
期刊: CANCER MEDICINE, 2021; 10 (13)
Background Apatinib is an oral anti-angiogenic drug, its efficacy and prognosis in cervical carcinoma are unclear. This study evaluates the effectiven......
期刊: CANCER MEDICINE, 2021; 10 (13)
Bladder cancer is a menace to global health worldwide due to its high recurrence rate and its progression to invasive muscular complications. Cell adh......
期刊: CANCER MEDICINE, 2021; 10 (14)
Background Information about global and local epidemiology and trends of skin cancers is limited, which increases the difficulty of cutaneous cancer c......
期刊: CANCER MEDICINE, 2021; 10 (15)
Background Patients with prostate cancer (PC) are at a high risk of developing secondary hematologic malignancies (SHMs) after radiation therapy (RT),......
期刊: CANCER MEDICINE, 2021; 10 (17)
Objectives To evaluate the clinical performance of liquid-based cytology (LBC), HPV tests and visual inspections with acetic acid or Lugol's iodine (V......
期刊: CANCER MEDICINE, 2021; 10 (17)
Introduction Pulmonary nuclear protein of the testis (NUT) midline carcinoma (NMC) is a aggressive cancer with t (15, 19) translocation. Here we prese......
期刊: CANCER MEDICINE, 2021; 10 (18)
Glioblastoma (GBM) is the most aggressive glioma, and is prone to develop resistance to chemotherapy and radiotherapy; hence, patients with glioblasto......
期刊: CANCER MEDICINE, 2021; 10 (11)
Hepatocellular carcinoma (HCC) is one of the most common public health challenges, worldwide. Because of molecular complexity and tumor heterogeneity,......
期刊: CANCER MEDICINE, 2021; 10 (15)
Background Human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) is a member of B7 family, which is upregulated in multiple......
期刊: CANCER MEDICINE, 2021; 10 (18)
Lung cancer is the leading cause of cancer-related death globally and poses a considerable threat to public health. Asia has the highest prevalence of......
期刊: CANCER MEDICINE, 2021; 10 (18)
Background Bladder cancer is the second most common malignant tumor in the urogenital system. The research investigated the prognostic role of immune-......